The median Effective Dose (ED50) and the 95% Effective Dose (ED95) of alfentanil in inhibiting responses to cervical dilation when combined with ciprofol during hysteroscopic procedure: a prospective, double-blind, dose-finding clinical study
The study was then registered on January 24, 2024 at the Chinese Clinical Trial Registry which participates in the World Health Organization International Clinical Trials Registry Platform (Identifier: ChiCTR2400080232) before enrolling the first participant and written informed consent was obtained by each patient.
Authors
- Shu-Xi Li
- Yanhong Zhou (ORCID: https://orcid.org/0000-0002-9498-4439)
- Jin-Peng Fu
- Xinzhong Chen (ORCID: https://orcid.org/0000-0001-9219-1681)
- Lili Xu (ORCID: https://orcid.org/0000-0002-1939-8720)
- Jianjun Shen (ORCID: https://orcid.org/0000-0003-3626-9936)
- Xing Li (ORCID: https://orcid.org/0000-0002-0568-8022)
- Gao Run
Institutions
- Hangzhou Women’s Hospital (CN)
- Suzhou Municipal Hospital (CN)
- Women's Hospital, School of Medicine, Zhejiang University (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Jinhua Central Hospital (CN)
Publication Details
- Journal
- BMC Anesthesiology
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1186/s12871-025-03217-5
- Citations
- 2
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Natural Science Foundation of China